About Navigenics
Navigenics is a company based in Foster City (United States) founded in 2006 by David Agus and Dietrich Stephan was acquired by Life Technologies in July 2012. Navigenics has raised $18 million across 1 funding round from investors including Procter & Gamble, Kleiner Perkins and Life Technologies. Navigenics offers products and services including Live Football Streaming Service. Navigenics operates in a competitive market with competitors including Viome, Invitae, Color, Everlywell and Variant Bio, among others.
- Headquarter Foster City, United States
- Founders David Agus, Dietrich Stephan
- SectorsHealthcare
- Website navigenics.com
- Social LinkedIn X
- Acquired by Life Technologies (Jul 2012)
- Legal Name Navigenics, Inc
- Total Equity Funding$18M (USD)
in 1 rounds
- Latest Funding Round$18M (USD), Series C
Feb 2010
- InvestorsProcter & Gamble
& 3 more
- Acquired byLife Technologies
(Jul 2012)
Products & Services of Navigenics
Navigenics offers a comprehensive portfolio of products and services, including Live Football Streaming Service.
Free platform for watching live football matches in HD quality.
Funding Insights of Navigenics
Navigenics has successfully raised a total of $18M through 1 strategic funding round. The most recent funding activity was a Series C round of $18 million completed in February 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18M
- Total Rounds 1
- Last Round Series C — $18M
- First Round $18M
(Feb 2010)
- Investors Count 3
All 1 funding rounds of Navigenics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2010 | $18M | Series C | – | – |
4 investors in total: 4 institutional.
Investors in Navigenics
Navigenics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Procter & Gamble, Kleiner Perkins and Life Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are managed in technology and healthcare sectors by this firm. | – | mdv.com | - | |
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Provider of FMCG conglomerate products | 1837 | pg.com | United States | |
Tools and technologies for biotech and biopharma research were supplied. | 1983 | lifetechnologies.com | Carlsbad, United States |
Investor details for Navigenics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Navigenics
3 people are tracked at Navigenics (3 in leadership).
| Name | Role | Group |
|---|---|---|
David Agus | Co-Founder | Leadership |
Dietrich Stephan | Co-Founder | Leadership |
Thomas Morris | Vice President GM Lab Operations | Leadership |
Complete people profiles for Navigenics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Navigenics
3 dated milestones of Navigenics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Navigenics is founded.
- Funding First funding round of $18.0M.
- Exit Acquired by Life Technologies.
Competitors of Navigenics
Navigenics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Color, Everlywell and Variant Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| color.com | 2013 | Burlingame, United States | $506.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| geneplanet.com | 2008 | Ljubljana, Slovenia | $34.02M | – | DNA-based personalized health and fitness recommendations are offered. | |
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| digbihealth.com | 2018 | Mountain View, United States | $5.4M | – | Personalized healthcare is delivered through DNA and gut biome testing. | |
| goodstartgenetics.com | 2008 | Boston, United States | $32.16M | – | Molecular diagnostics for inherited genetic disease screening are provided. |
Detailed competitors of Navigenics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Navigenics
Websites that share an audience with Navigenics (navigenics.com).
Websites whose visitors overlap most with Navigenics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| decode.com | 100% | 13.6K | #1,966,785 | View details | |
| pathway.com | 100% | 77.6K | #436,968 | View details | |
| genedx.com | 84% | 129.4K | #317,801 | View details | |
| dna.com | 84% | – | – | View details | |
mostgene.org | mostgene.org | 83% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Navigenics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Navigenics
10 companies that operate in the same segment as Navigenics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Navigenics
Navigenics was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Navigenics is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
Navigenics is a funded company, having raised a total of $18M across 1 funding round to date. The company's 1st funding round was a Series C of $18M, raised on Feb 2010.
Navigenics, a personal genomics company, that uses genetic testing to help people determine their individual risk for dozens of health conditions. It helps educate and empower individuals and their physicians with knowledge of their genetic predispositions and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. In July 2012, Navigenics was acquired by Life Technologies which was acquired by Thermo Fisher Scientific in February 2014.
Navigenics's top competitors include Viome, Variant Bio and Newtopia.
Navigenics offers Live Football Streaming Service.
Navigenics has 4 investors. Key investors include Procter & Gamble, Kleiner Perkins, Life Technologies, and Mohr Davidow Ventures.
Navigenics operates through Navigenics, Inc.
Yes. Navigenics was acquired by Life Technologies in July 2012.